Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety follow-up of lacosamide versus controlled-release carbamazepine monotherapy in epilepsy
2010-021238-74Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lacosamide and carbamazepine in epilepsy, Focal onset seizure and tonic-clonic seizure (GTCS) (2 arms), sponsored by UCB. Primary endpoint: Primary safety variables. Started Oct 2010; status: completed.
02
Drugs
lacosamidecarbamazepine
03
Conditions
epilepsyFocal onset seizuretonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on 2010-021238-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021238-74.